The Effect of Velaglucerase Alfa (Vpriv) on Skeletal Development in Pediatric Gaucher Disease
Clinical trial NCT02528617 · WITHDRAWN
Trial details
- NCT number
- NCT02528617
- Sponsor
- Baylor Research Institute
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2017-10-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.